Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Majoor

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
ERJ Open Research|April 26, 2021
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patientsAnne H Neerincx, Katrine Whiteson, Joann L Phan, et al.
Pediatric Pulmonology|August 9, 2019
Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and coughJennifer J Meerburg, Mehdi Albasri, Els C van der Wiel, et al.
Calcified Tissue International|November 23, 2020
Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)M Hagelstein-Rotman, M E Meier, B C J Majoor, et al.
Allergy|April 2, 2019
Eosinophils capture viruses, a capacity that is defective in asthmaYanaika S Sabogal Piñeros, Suzanne M Bal, Annemiek Dijkhuis, et al.
The Journal of Bone and Joint Surgery. American Volume|January 18, 2019
Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European StudyBas C J Majoor, Michiel A J van de Sande, Natasha M Appelman-Dijkstra, et al.
Pharmacology Research & Perspectives|November 28, 2022
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patientsRenate Kos, Anne H Neerincx, Dominic W Fenn, et al.
Allergy|September 20, 2019
Effect of C1-inhibitor in adults with mild asthma: A randomized controlled trialJack Yang, Tjitske S R van Engelen, Bastiaan W Haak, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 20, 2017
Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthmaP Brinkman, M A van de Pol, M G Gerritsen, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2018
Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind StudyYanaika S Sabogal Piñeros, Suzanne M Bal, Marianne A van de Pol, et al.
Respiratory Research|February 8, 2014
Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational studyChristof J Majoor, Marianne A van de Pol, Pieter Willem Kamphuisen, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
ERJ Open Research|April 26, 2021
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patientsAnne H Neerincx, Katrine Whiteson, Joann L Phan, et al.
Pediatric Pulmonology|August 9, 2019
Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and coughJennifer J Meerburg, Mehdi Albasri, Els C van der Wiel, et al.
Calcified Tissue International|November 23, 2020
Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)M Hagelstein-Rotman, M E Meier, B C J Majoor, et al.
Allergy|April 2, 2019
Eosinophils capture viruses, a capacity that is defective in asthmaYanaika S Sabogal Piñeros, Suzanne M Bal, Annemiek Dijkhuis, et al.
The Journal of Bone and Joint Surgery. American Volume|January 18, 2019
Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European StudyBas C J Majoor, Michiel A J van de Sande, Natasha M Appelman-Dijkstra, et al.
Pharmacology Research & Perspectives|November 28, 2022
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patientsRenate Kos, Anne H Neerincx, Dominic W Fenn, et al.
Allergy|September 20, 2019
Effect of C1-inhibitor in adults with mild asthma: A randomized controlled trialJack Yang, Tjitske S R van Engelen, Bastiaan W Haak, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 20, 2017
Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthmaP Brinkman, M A van de Pol, M G Gerritsen, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2018
Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind StudyYanaika S Sabogal Piñeros, Suzanne M Bal, Marianne A van de Pol, et al.
Respiratory Research|February 8, 2014
Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational studyChristof J Majoor, Marianne A van de Pol, Pieter Willem Kamphuisen, et al.
Pageof 6